Monopar Therapeutics
MNPR
$0.60
Share price
-9.38%
Change (1 day)
-30.45%
Change (1 year)
Categories
Monopar Therapeutics (MNPR) - P/B ratio
P/B ratio as of May 2024 : 1.94
According to Monopar Therapeutics's latest financial reports the company has a price-to-book ratio of 1.94.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Monopar Therapeutics - P/B ratio (from 2019 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.9051 | -70.18% |
| 2022-12-31 | 3.03 | 42.15% |
| 2021-12-31 | 2.14 | -52.2% |
| 2020-12-31 | 4.47 | -67.91% |
| 2019-12-31 | 13.9 | |
| 2018-12-31 | N/A | |
| 2017-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.80 | 44.58% | 🇺🇸 USA |